Clinical Trials Logo

Substance P clinical trials

View clinical trials related to Substance P.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03306134 Recruiting - Swallowing Disorder Clinical Trials

The Effect of Beta-blockers in Substance P Levels and the Swallowing Function

BETASP
Start date: June 5, 2017
Phase: N/A
Study type: Observational

A non-randomised, prospective study to assess the effects of beta-blockers on substance P levels and the swallowing function. The study is going to be carry out in the Gastrointestinal Physiology Laboratory of the Hospital de Mataró (Spain). All participants will be actively recruited from a Linked hospital and primary care database. We include two groups: the first group (group 1) are participants taking beta-blockers and the second group (group 2) are participants not-taking beta-blockers.